11 C-acetate uptake in hepatocellular carcinoma (HCC) was reported and the modeling study has been conducted, in which the weighted nonlinear least squares (NLS) algorithm was used to estimate all of the parameters. However, the computational timecomplexity of NLS method is high and some estimates are not quite reliable. Due to the hepatic dual blood supply, the current developed fast algorithms could not be used directly. In this paper, two new estimation approaches were presented: Patlak-NLS and Patlak-dual-input-generalized linear least squares. The estimation results demonstrated that these two methods could provide better and practical ways for dual-input 11 C-acetate liver kinetic modeling.
INTRODUCTION
Application of the tracer kinetic modeling technique in positron emission tomography (PET) could provide significant diagnostic information for various kinds of disease detection. Quantitative PET using labeled 11 C-acetate provides the ability to evaluate non-18 F-fluorodeoxyglucose (FDG)-avid hepatocellular carcinoma (HCC) (Ho, et al., 2003; , a highly malignant tumor. A three-compartment model describing 11 C-acetate liver kinetics with an extra parameter (relative portal venous contribution to the hepatic blood supply) included in the model input function to account for the dual source of liver blood supply has been proposed and validated by . In the previous modeling studies, all of the parameters were estimated by using the weighted nonlinear least squares (NLS) algorithm. However, due to the relative large number of parameters to be estimated, the computational time-complexity is high, the fitting results are a bit more sensitive to the initial guess, and some estimates are not quite reliable, which limits its routing application in the clinical environments.
With the development of high spatial and temporal resolution PET, a variety of rapid parameter estimation methodologies have been developed (Huang, et al., 1982; Patlak, et al., 1983; Carson, et al., 1986; Feng, et al., 1996; Chen, et al., 1998) . All these computationally efficient techniques are to identify single input systems, and could not provide solutions for dual-input biomedical systems directly. Therefore, practical algorithms are needed to be developed for the parameter estimation of dual-input 11 C-acetate liver kinetic model to detect HCC.
In this study, two novel parameter estimation approaches for 11 C-acetate kinetic model of dualinput liver system were presented: Patlak-NLS and Patlak-dual-input-generalized linear least squares (Patlak-D-I-GLLS) algorithms. The performance in terms of the estimation reliability and accuracy of Patlak-NLS and Patlak-D-I-GLLS techniques were evaluated by the clinical datasets and computer simulation respectively.
METHODS

Human studies.
The study population comprised six subjects with two suffered from HCC. Dynamic PET images were recorded for 10 min after injection of 11 C-acetate as 25 frames with the following scan durations: 10×4, 8×10, 2×30, 3×60 and 2×120 sec. Time-activity curve (TAC) was generated by placing a region of interest (ROI) on single transverse slice of the full set of dynamic PET images. Eight ROIs were extracted from nontumor liver tissue of the six patients and two HCC regions were extracted from the two patients suffered from HCC. The TAC in blood (BTAC) consisting of the hepatic artery (HA) and portal vein (PV), whose TACs were image derived, was used as the model input function. As suggested by Munk et al. (2001) that after some time the TACs of HA and PV are virtually identical, to avoid the radioactivity spillover from the surrounding tissue to the PV, the last five measurements of the PV were replaced by the corresponding HA data in this study.
11 C-acetate kinetic model in liver.
The dual-input 11 C-acetate liver kinetic model was proposed by , which consists of three compartments (Fig. 1) , corresponding to the intravascular 11 C-acetate concentration, the intracellular free 11 C-acetate and the intracellular 11 C-acetate products/metabolites converted from 11 Cacetate (acetyl-CoA, and metabolites of fatty acid synthesis). HBV (hepatic blood volume) is to account for the contribution of 11 C-acetate within vascular/sinus space of liver tissue to the observed total tissue activity. The differential equations describing the kinetics of 11 C-acetate in liver are given by
where K 1 -k 3 are the rate constants, c b (t) and c e (t) are the 11 C-acetate concentration in intravascular and intracellular space respectively, c m (t) is the intracellular products/metabolites concentration. The observed total tissue activity c T (t), is given by
where c a (t) and c v (t) are the tracer concentration in the HA and PV respectively, and a v is to account for the relative portal venous contribution to the hepatic blood supply. 
Patlak-nonlinear least squares algorithm.
The parameter estimation procedure of this Patlak-NLS technique has the following three steps.
1. Linear Patlak method is applied to estimate the HCC indicator "local hepatic metabolic rate-constant of acetate (LHMRAct)" formulated as K 1 *k 3 /(k 2 +k 3 ) (the forward clearance K) . The data to be fitted are from 3 min to 10 min, when the two TACs of HA and PV are almost virtually identical. To calculate the dual-input function, a v was fixed as 0.8 for the first iteration. 2. Since K 1 *k 3 /(k 2 +k 3 ) is one of the macroparameters of the 11 C-acetate model, the weighted NLS algorithm is utilized to estimate HBV, a v and the other two macroparameters: K 1 *k 2 /(k 2 +k 3 ) and (k 2 +k 3 ). This fitting procedure is to minimize the weighted residual sum of squares (WRSS). The weights used are proportional to the frame duration divided by the concentration value of that time point. If the difference between the estimated a v by this NLS regression and the a v value utilized in step 1 is greater than 0.2, which may generally indicate the tumor case, steps 1 and 2 would be performed again. The estimated a v would be used to calculate the dual-input function in step 1. For nontumor cases, the iteration generally would not be repeated since the a v value obtained by the previous quantitative study ) is 0.7935 ± 0.1040; for tumor cases, one more iteration is generally needed. 3. Parameter K would be estimated by Patlak method with the updated a v value in step 2 to calculate the dual-input function. The fitting results by Patlak-NLS approach were compared with those obtained from NLS method. The coefficient of variation (CV) was adopted as the statistical criterion to access the reliability of the parameter estimation.
Patlak-dual-input-generalized linear least squares algorithm.
The Patlak-D-I-GLLS technique is a novel fast estimation algorithm consisting of four steps. The first step estimation is the same as that involved in the Patlak-NLS algorithm. The second step estimation is Patlak-dual-input-linear least squares (Patlak-D-I-LLS) proposed in this paper. The second-order differential equation of the 11 C-acetate liver kinetic model could be expressed as
Substitute K 1 k 3 in eq. (6) by , where ) (
is the estimation value in step one. Let P 0 =HBV, P 1 =K 1 +(k 2 +k 3 )HBV, and P 2 =k 2 +k 3 , then,
To formulate the Patlak-D-I-LLS solution, substitute c b (t) in the first term of eq. (7) with eq. (5) and assume the initial conditions were all zeros, the observed total tissue activity c T 
where
T are the PET measurements at the sampling time, θ=[P 0 , P 1 , P 2 ,
T are the parameters to be estimated and X is the coefficient matrix. The initial guess of a v is needed to calculate the dual-input function in the third and fourth terms of eq. 
where K (s s is the estimate in step one, P represent the most updated estimates. Take the Laplace transform of eq. (11) with the assumption that the initial conditions were all zeros, whiten the correlated equation errors with an autoregressive filter , and then take the inverse Laplace transform, the time domain output function is 2 1 0, where r is the filtered PET measurements at the sampling time, ζ is the filtered equation errors, θ=[P 0 ,
T are the parameters to be estimated, and Z is the coefficient matrix. The solution of the Patlak-
where represents the estimated θ in Patlak-D-I-GLLS sense. Eq. (14) would be repeated until the termination criteria are satisfied. In this study, the termination criteria are either maximum iteration of twenty was reached or the Euclidean norm of difference of parameter estimates between two successive iterations was less than 0.0001. In the fourth step estimation, Parameter K would be estimated by Patlak method with the estimated a GLLS I D P − − − θˆv in step three to calculate the dual-input function.
Simulation studies.
Computer simulation was conducted to both NLS and Patlak-D-I-GLLS algorithms. There were two sets of computer simulated data including one representing HCC with two image-derived dual-input functions acquired from two patients recruited in this study. The sampling sequences were the same as those of clinical data acquisition. A pseudorandom number generator was used to generate the Gaussian noise added to the calculated tissue TAC (TTAC) and the noise level (the proportional constant in the variance of the generated noise) was set to 0.1, 0.5 and 1.0 respectively. The estimation accuracy and reliability were evaluated by bias and CV respectively.
RESULTS AND CONCLUSION
In Patlak-NLS fitting, the estimation of LHMRAct (the forward clearance K) is by linear Gjedde-Patlak analysis, it is generally accepted that the fitting results are very robust. The estimation reliability in terms of the CV of another two macroparameters is satisfactory as well. The CVs of all the macroparameters are generally less than the CV of the most reliably estimated K 1 by NLS method. Therefore, the model rate constant parameters K 1 , k 2 , k 3 could be much more reliably estimated by the proposed Patlak-NLS technique.
The fitting results of a v and HBV by NLS and Patlak-NLS methods were summarized in Table 1 . As could be seen, the two sets of estimated a v values are approximately the same except region 8. For the eight nontumor liver tissue regions, the estimated a v values are 0.8174 ± 0.0898 and 0.7935 ± 0.1040 by Patlak-NLS and NLS methods respectively. The estimation of a v by Patlak-NLS is reliable, since half of the CVs are less than 10% and most of them are less than 20%. Majority CVs of the estimated a v by Patlak-NLS are less than those by NLS, and the estimated a v of region 10 is considerably more reliable. All these findings suggest that Patlak-NLS method could provide accurate and reliable fitting results for the potential HCC indicator: Parameter a v . The estimates of HBV by the two methods are nearly the same except regions 1 and 8. The estimation of HBV tends to be slightly less reliable than that by NLS in some cases. However, the estimation of HBV of region 10 is significantly more reliable, the average CV is a little bit smaller and all the CVs of the estimated HBV are generally acceptable. The fitted curves of the generated TACs of HCC and nontumor liver tissue ROIs by using patlak-NLS and NLS methods were demonstrated in Fig. 2 . As shown in Fig. 2 , the two fitted curves for HCC by the two methods are identical to each other; for the nontumor liver tissue data, the curve fitted by Patlak-NLS demonstrates better results. During the Patlak-NLS fitting procedure, the number of parameters to be estimated by the recursive NLS procedure is reduced, therefore, the fitting results are less affected by the initial guess and the computational time-complexity is considerably reduced. Table 2 . As seen in Table 2 , the estimation quality in terms of CV and bias of the estimated a v and HBV by Patlak-D-I-GLLS is comparable with that by NLS method.
Parameter a v could be reliably and accurately identified by using Patlak-D-I-GLLS. More reliable estimates of K could be provided by Patlak-D-I-GLLS than by NLS and the rate constant parameters K 1 -k 3 could be considerably more reliably estimated as well. The estimation accuracy of K and K 1 -k 3 is satisfactory. The accuracy of the estimated K 1 -k 3 is less sensitive to the noise level and the accuracy of the two HCC indicators: a v and LHMRAct (the forward clearance K) is not sensitive to the noise level at all. Furthermore, since all of the parameters could be estimated by linear fitting and calculated analytically, the Patlak-D-I-GLLS procedure is significantly faster. Therefore, Patlak-D-I-GLLS is particularly valuable for noisy clinical environments.
Two novel parameter estimation techniques for dualinput 11 C-acetate kinetic model with dynamic PET images were presented in this study. When compared with NLS method, the computational timecomplexity of Patlak-NLS technique is reduced, the fitting results are less affected by the initial guess and more reliable estimates could be provided. Patlak-D-I-GLLS algorithm could generally identify all the parameters more reliably including the parameter in the dual-input function and the fitting procedure is significantly faster. The estimation accuracy and reliability of the two HCC indicators are satisfactory by both presented methods. Therefore, the proposed approaches suggest better ways for the evaluation of HCC, and are potentially applicable for other dualinput biomedical systems. 
